| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 25 | 2025 | 1471 | 3.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 16 | 2025 | 411 | 2.570 |
Why?
|
| Hedgehog Proteins | 15 | 2017 | 109 | 2.420 |
Why?
|
| Nuclear Proteins | 9 | 2025 | 750 | 1.720 |
Why?
|
| DNA-Binding Proteins | 12 | 2025 | 1151 | 1.690 |
Why?
|
| Carcinogenesis | 5 | 2025 | 118 | 1.620 |
Why?
|
| Trans-Activators | 12 | 2022 | 300 | 1.370 |
Why?
|
| Mesoderm | 6 | 2017 | 81 | 1.180 |
Why?
|
| Signal Transduction | 33 | 2025 | 2903 | 1.170 |
Why?
|
| Phosphoproteins | 12 | 2025 | 211 | 1.160 |
Why?
|
| Cell Cycle Proteins | 7 | 2023 | 384 | 1.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2024 | 106 | 1.060 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2025 | 9 | 0.970 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2014 | 48 | 0.960 |
Why?
|
| Acupuncture Therapy | 3 | 2022 | 13 | 0.960 |
Why?
|
| Sarcoma | 1 | 2025 | 36 | 0.950 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 54 | 0.940 |
Why?
|
| Pancreatic Neoplasms | 3 | 2024 | 331 | 0.920 |
Why?
|
| Gastrointestinal Tract | 3 | 2017 | 170 | 0.880 |
Why?
|
| Mice | 39 | 2025 | 10294 | 0.870 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2022 | 1 | 0.810 |
Why?
|
| Neoplasms | 4 | 2022 | 1231 | 0.780 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 263 | 0.780 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 55 | 0.760 |
Why?
|
| Animals | 49 | 2025 | 19649 | 0.710 |
Why?
|
| Cell Differentiation | 9 | 2025 | 1304 | 0.700 |
Why?
|
| Intestines | 3 | 2020 | 158 | 0.680 |
Why?
|
| Transcription, Genetic | 7 | 2024 | 841 | 0.670 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 51 | 0.660 |
Why?
|
| Wnt Proteins | 11 | 2013 | 91 | 0.620 |
Why?
|
| Nerve Tissue Proteins | 6 | 2016 | 418 | 0.600 |
Why?
|
| Receptors, G-Protein-Coupled | 6 | 2013 | 124 | 0.600 |
Why?
|
| Stem Cells | 5 | 2020 | 255 | 0.590 |
Why?
|
| Zinc Finger Protein Gli2 | 4 | 2024 | 26 | 0.580 |
Why?
|
| Mice, Transgenic | 13 | 2024 | 1206 | 0.570 |
Why?
|
| Epithelium | 1 | 2017 | 96 | 0.560 |
Why?
|
| Medical Oncology | 1 | 2017 | 57 | 0.550 |
Why?
|
| Zinc Finger Protein GLI1 | 6 | 2022 | 31 | 0.550 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 48 | 0.540 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 276 | 0.520 |
Why?
|
| Melanoma | 1 | 2019 | 318 | 0.510 |
Why?
|
| Transcription Factor AP-1 | 1 | 2016 | 41 | 0.510 |
Why?
|
| Rhabdomyosarcoma | 2 | 2013 | 16 | 0.510 |
Why?
|
| beta Catenin | 4 | 2013 | 86 | 0.500 |
Why?
|
| Muscle Proteins | 1 | 2016 | 111 | 0.480 |
Why?
|
| Cell Proliferation | 8 | 2020 | 941 | 0.480 |
Why?
|
| Zebrafish Proteins | 8 | 2004 | 151 | 0.480 |
Why?
|
| Cell Lineage | 3 | 2013 | 259 | 0.470 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2015 | 327 | 0.470 |
Why?
|
| Repressor Proteins | 5 | 2021 | 331 | 0.450 |
Why?
|
| Proteins | 9 | 2005 | 730 | 0.450 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2012 | 318 | 0.450 |
Why?
|
| GTP-Binding Proteins | 3 | 1998 | 81 | 0.450 |
Why?
|
| Cell Movement | 1 | 2016 | 428 | 0.440 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2013 | 13 | 0.430 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2013 | 10 | 0.430 |
Why?
|
| Body Patterning | 2 | 2014 | 80 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2023 | 193 | 0.400 |
Why?
|
| Genes, ras | 1 | 2012 | 27 | 0.390 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2002 | 118 | 0.390 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 1368 | 0.390 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2025 | 194 | 0.390 |
Why?
|
| Hemangioendothelioma, Epithelioid | 2 | 2021 | 7 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 474 | 0.360 |
Why?
|
| Drosophila melanogaster | 4 | 2021 | 481 | 0.360 |
Why?
|
| Zinc Finger Protein Gli3 | 3 | 2016 | 9 | 0.350 |
Why?
|
| Mammals | 2 | 2010 | 209 | 0.350 |
Why?
|
| Receptors, LDL | 4 | 2004 | 33 | 0.340 |
Why?
|
| Intestinal Mucosa | 4 | 2019 | 225 | 0.330 |
Why?
|
| Smoothened Receptor | 6 | 2013 | 26 | 0.330 |
Why?
|
| Receptors, Cell Surface | 4 | 2014 | 428 | 0.330 |
Why?
|
| Gene Expression Regulation | 4 | 2005 | 1552 | 0.320 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2009 | 4 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2009 | 19 | 0.320 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 156 | 0.320 |
Why?
|
| Extremities | 1 | 2009 | 44 | 0.310 |
Why?
|
| Humans | 27 | 2025 | 59366 | 0.310 |
Why?
|
| Vertebrates | 1 | 2009 | 41 | 0.310 |
Why?
|
| 3T3 Cells | 10 | 2002 | 108 | 0.300 |
Why?
|
| Neoplasms, Experimental | 2 | 2009 | 75 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2021 | 619 | 0.280 |
Why?
|
| Cells, Cultured | 4 | 2013 | 2092 | 0.280 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2023 | 167 | 0.270 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2013 | 33 | 0.270 |
Why?
|
| Protein Binding | 5 | 2020 | 1555 | 0.260 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2053 | 0.260 |
Why?
|
| Drosophila Proteins | 3 | 2018 | 679 | 0.250 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2025 | 2 | 0.250 |
Why?
|
| Zona Glomerulosa | 1 | 2025 | 1 | 0.250 |
Why?
|
| Adrenal Cortex | 1 | 2025 | 3 | 0.240 |
Why?
|
| Immunoblotting | 2 | 2017 | 188 | 0.240 |
Why?
|
| Disease Progression | 2 | 2019 | 1119 | 0.230 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2002 | 59 | 0.220 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 1951 | 0.220 |
Why?
|
| Integrin alpha6beta1 | 2 | 2015 | 34 | 0.220 |
Why?
|
| Integrases | 3 | 2009 | 36 | 0.200 |
Why?
|
| Interleukin-33 | 1 | 2022 | 18 | 0.200 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 31 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 527 | 0.200 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 169 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 83 | 0.190 |
Why?
|
| Gene Deletion | 2 | 2021 | 293 | 0.190 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 117 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2019 | 205 | 0.190 |
Why?
|
| Vascular Neoplasms | 1 | 2021 | 16 | 0.180 |
Why?
|
| Genomic Instability | 1 | 2021 | 53 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2018 | 608 | 0.180 |
Why?
|
| Stomach Neoplasms | 1 | 2021 | 69 | 0.180 |
Why?
|
| COS Cells | 5 | 2002 | 173 | 0.180 |
Why?
|
| DNA Transposable Elements | 1 | 2021 | 127 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 83 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 125 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2021 | 173 | 0.170 |
Why?
|
| Phosphorylation | 6 | 2019 | 883 | 0.170 |
Why?
|
| SOXC Transcription Factors | 2 | 2022 | 9 | 0.160 |
Why?
|
| Melanocytes | 1 | 2019 | 77 | 0.160 |
Why?
|
| Kidney | 1 | 2021 | 414 | 0.160 |
Why?
|
| Mice, 129 Strain | 2 | 2020 | 37 | 0.150 |
Why?
|
| Skin Neoplasms | 2 | 2018 | 397 | 0.150 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 26 | 0.150 |
Why?
|
| Yeasts | 1 | 2018 | 51 | 0.150 |
Why?
|
| Alleles | 3 | 2015 | 411 | 0.140 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 33 | 0.140 |
Why?
|
| Medulloblastoma | 2 | 2008 | 11 | 0.140 |
Why?
|
| Acyltransferases | 1 | 2017 | 31 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2019 | 587 | 0.140 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2016 | 2 | 0.140 |
Why?
|
| Heterografts | 1 | 2017 | 61 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 31 | 0.130 |
Why?
|
| Transfection | 6 | 2016 | 675 | 0.130 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2016 | 19 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2018 | 486 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2013 | 152 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 31 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 236 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 127 | 0.130 |
Why?
|
| RNA Interference | 3 | 2016 | 590 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 2 | 2015 | 196 | 0.130 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2015 | 1 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 191 | 0.130 |
Why?
|
| Mutation | 4 | 2019 | 2456 | 0.130 |
Why?
|
| Disease Management | 1 | 2017 | 220 | 0.130 |
Why?
|
| Amino Acid Sequence | 6 | 2013 | 1553 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 442 | 0.120 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 96 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2016 | 245 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 1118 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 248 | 0.120 |
Why?
|
| Female | 11 | 2020 | 30719 | 0.120 |
Why?
|
| Macrophages | 1 | 2020 | 1015 | 0.120 |
Why?
|
| Serum Response Factor | 3 | 1998 | 5 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2017 | 256 | 0.120 |
Why?
|
| Laminin | 1 | 2015 | 74 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 847 | 0.120 |
Why?
|
| Regeneration | 1 | 2014 | 93 | 0.110 |
Why?
|
| PAX7 Transcription Factor | 1 | 2013 | 9 | 0.110 |
Why?
|
| Genome, Human | 1 | 2016 | 224 | 0.110 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2013 | 13 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 132 | 0.110 |
Why?
|
| Rhabdomyoma | 1 | 2013 | 1 | 0.110 |
Why?
|
| Muscle Neoplasms | 1 | 2013 | 7 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2014 | 142 | 0.110 |
Why?
|
| Frameshift Mutation | 1 | 2013 | 29 | 0.110 |
Why?
|
| Aging | 1 | 2019 | 710 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 107 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2016 | 1465 | 0.110 |
Why?
|
| Exocrine Glands | 1 | 2013 | 1 | 0.110 |
Why?
|
| Edar Receptor | 1 | 2013 | 1 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2013 | 1997 | 0.110 |
Why?
|
| Base Sequence | 1 | 2016 | 1302 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 113 | 0.100 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 173 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 217 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 450 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2013 | 32 | 0.100 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 57 | 0.100 |
Why?
|
| Neuropilin-2 | 1 | 2013 | 39 | 0.100 |
Why?
|
| Hair | 1 | 2013 | 78 | 0.100 |
Why?
|
| Models, Animal | 1 | 2013 | 221 | 0.100 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 39 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 294 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2013 | 583 | 0.100 |
Why?
|
| Biological Evolution | 1 | 2013 | 114 | 0.100 |
Why?
|
| Luciferases | 3 | 2002 | 106 | 0.090 |
Why?
|
| Protein Transport | 2 | 2003 | 399 | 0.090 |
Why?
|
| Neurons | 2 | 2008 | 863 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2011 | 21 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2011 | 101 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1143 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 674 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2002 | 27 | 0.090 |
Why?
|
| Gastrula | 1 | 2010 | 12 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2010 | 15 | 0.090 |
Why?
|
| Axin Protein | 4 | 2007 | 10 | 0.080 |
Why?
|
| Genes, Reporter | 4 | 2007 | 241 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 51 | 0.080 |
Why?
|
| Organogenesis | 1 | 2010 | 38 | 0.080 |
Why?
|
| NF-kappa B | 1 | 2012 | 460 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 461 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 718 | 0.080 |
Why?
|
| Histones | 2 | 2024 | 457 | 0.080 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 137 | 0.080 |
Why?
|
| Polydactyly | 1 | 2009 | 1 | 0.080 |
Why?
|
| Ectoderm | 1 | 2009 | 11 | 0.080 |
Why?
|
| Paired Box Transcription Factors | 1 | 2009 | 16 | 0.080 |
Why?
|
| Male | 9 | 2020 | 27742 | 0.080 |
Why?
|
| Chick Embryo | 1 | 2009 | 42 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 178 | 0.080 |
Why?
|
| Hematopoiesis | 1 | 2009 | 120 | 0.080 |
Why?
|
| Thrombin | 2 | 1998 | 21 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 490 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2009 | 110 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 2 | 1998 | 64 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2024 | 650 | 0.070 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 3 | 2004 | 4 | 0.070 |
Why?
|
| LDL-Receptor Related Proteins | 3 | 2004 | 5 | 0.070 |
Why?
|
| Phenotype | 3 | 2020 | 1137 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 3231 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2009 | 276 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2013 | 288 | 0.070 |
Why?
|
| Patched Receptors | 3 | 2014 | 10 | 0.070 |
Why?
|
| Cell Line | 3 | 2011 | 1983 | 0.070 |
Why?
|
| Gastric Mucosa | 1 | 2007 | 51 | 0.070 |
Why?
|
| Stomach | 1 | 2007 | 83 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2007 | 108 | 0.070 |
Why?
|
| Carrier Proteins | 2 | 2003 | 697 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2001 | 40 | 0.070 |
Why?
|
| Spleen | 1 | 2007 | 479 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 151 | 0.060 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2006 | 63 | 0.060 |
Why?
|
| Xenopus Proteins | 2 | 2003 | 35 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 35 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 254 | 0.060 |
Why?
|
| Chimera | 1 | 2005 | 40 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 3 | 2004 | 656 | 0.060 |
Why?
|
| Doxycycline | 1 | 2005 | 42 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2005 | 35 | 0.060 |
Why?
|
| Cell Transdifferentiation | 1 | 2025 | 13 | 0.060 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 101 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 356 | 0.060 |
Why?
|
| United States | 1 | 2017 | 7426 | 0.060 |
Why?
|
| Gene Expression | 2 | 2013 | 809 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2007 | 391 | 0.060 |
Why?
|
| Dishevelled Proteins | 5 | 2003 | 6 | 0.060 |
Why?
|
| Patched-1 Receptor | 2 | 2014 | 13 | 0.060 |
Why?
|
| Binding Sites | 3 | 2016 | 881 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 188 | 0.060 |
Why?
|
| Neural Crest | 1 | 2004 | 26 | 0.060 |
Why?
|
| Face | 1 | 2004 | 33 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2005 | 253 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 99 | 0.050 |
Why?
|
| Ovum | 1 | 2003 | 61 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2003 | 111 | 0.050 |
Why?
|
| Lipoylation | 1 | 2022 | 4 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2002 | 76 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2002 | 4 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 26 | 0.050 |
Why?
|
| Cicatrix | 1 | 2022 | 59 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 153 | 0.050 |
Why?
|
| Point Mutation | 1 | 2002 | 160 | 0.050 |
Why?
|
| Bone Density | 1 | 2002 | 129 | 0.050 |
Why?
|
| Time Factors | 2 | 2007 | 3615 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 75 | 0.050 |
Why?
|
| Cysteine | 1 | 2001 | 107 | 0.050 |
Why?
|
| Cadherins | 1 | 2021 | 68 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2020 | 9 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 471 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 193 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 129 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 377 | 0.040 |
Why?
|
| Heart | 1 | 2022 | 274 | 0.040 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 4 | 2000 | 10 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2021 | 343 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 229 | 0.040 |
Why?
|
| Endothelins | 1 | 1998 | 3 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1998 | 7 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1998 | 9 | 0.040 |
Why?
|
| Myocardium | 1 | 2020 | 264 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 1998 | 23 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Epidermis | 1 | 2018 | 35 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1998 | 132 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 29 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 62 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 914 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 1998 | 297 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 277 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 117 | 0.030 |
Why?
|
| Arsenicals | 1 | 2016 | 7 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2016 | 33 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 18 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 3 | 2007 | 196 | 0.030 |
Why?
|
| Oxides | 1 | 2016 | 33 | 0.030 |
Why?
|
| Digestion | 1 | 2018 | 135 | 0.030 |
Why?
|
| Kinetics | 1 | 1998 | 751 | 0.030 |
Why?
|
| Chromatin | 1 | 2021 | 599 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2011 | 253 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 857 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 179 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2001 | 359 | 0.030 |
Why?
|
| Cilia | 1 | 2016 | 158 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 805 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 559 | 0.030 |
Why?
|
| Quality of Life | 1 | 2021 | 1137 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1098 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 861 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 644 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 52 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 411 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2013 | 3 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Cell Division | 1 | 2014 | 443 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 34 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 152 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 188 | 0.030 |
Why?
|
| Scalp | 1 | 2013 | 29 | 0.030 |
Why?
|
| Haplotypes | 1 | 2013 | 115 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 234 | 0.020 |
Why?
|
| Xenopus | 2 | 2003 | 54 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 516 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2011 | 14 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 628 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2011 | 90 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 61 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2013 | 298 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 439 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 280 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 170 | 0.020 |
Why?
|
| Glycogen Synthase Kinases | 2 | 1999 | 2 | 0.020 |
Why?
|
| Wnt1 Protein | 2 | 1999 | 12 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 1283 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2009 | 28 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1491 | 0.020 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 105 | 0.020 |
Why?
|
| Cerebrum | 1 | 2008 | 16 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2008 | 36 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2001 | 689 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1792 | 0.020 |
Why?
|
| WT1 Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 124 | 0.020 |
Why?
|
| Transcription Factor 4 | 1 | 2007 | 2 | 0.020 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2007 | 5 | 0.020 |
Why?
|
| Microvilli | 1 | 2007 | 4 | 0.020 |
Why?
|
| Cyclin D | 1 | 2007 | 4 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 6 | 0.020 |
Why?
|
| Endoderm | 1 | 2007 | 45 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2007 | 35 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 214 | 0.020 |
Why?
|
| Cyclins | 1 | 2007 | 40 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2007 | 77 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2009 | 167 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2004 | 850 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 96 | 0.020 |
Why?
|
| Skull | 1 | 2004 | 50 | 0.010 |
Why?
|
| Child | 1 | 2013 | 4187 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4273 | 0.010 |
Why?
|
| Mandible | 1 | 2002 | 7 | 0.010 |
Why?
|
| Palate | 1 | 2002 | 8 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2002 | 13 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 55 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 5835 | 0.010 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2001 | 3 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 170 | 0.010 |
Why?
|
| Pedigree | 1 | 2002 | 183 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 149 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2002 | 172 | 0.010 |
Why?
|
| Osteogenesis | 1 | 2002 | 140 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2000 | 111 | 0.010 |
Why?
|
| Radiography | 1 | 2002 | 516 | 0.010 |
Why?
|
| Static Electricity | 1 | 2000 | 163 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 617 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 333 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 365 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1051 | 0.010 |
Why?
|
| Protein Folding | 1 | 2000 | 260 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1999 | 365 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 1306 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 1128 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 763 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 15679 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 16310 | 0.010 |
Why?
|